SEC Form 4 · accession 0001214659-18-004880
Mirati Therapeutics, Inc. · MRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Isan Chen
Officer — EVP, Chief Medical Officer
Period of report
Jul 16, 2018
Accepted (ET)
Jul 17, 2018 · 7:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 16, 2018 | M | 275 | $17.41 | A | 32,111 | D | |
| Common StockF1 | Jul 16, 2018 | M | 1,592 | $21.51 | A | 34,582 | D | |
| Common Stock | holding | — | — | — | 110 | I | By Chen Living Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $17.41 | Jul 16, 2018 | M | 275 | D | — | May 20, 2024 | Common Stock | 275 | 5,913 | D |
| Employee Stock Option (Right to Buy)F2 | $21.51 | Jul 16, 2018 | M | 1,592 | D | — | Feb 3, 2025 | Common Stock | 1,592 | 25,908 | D |
Explanation of responses
- F1Includes 879 shares acquired under the ESPP Purchase on 05/31/18.
- F21/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.